2(3H)-Benzoxazolone, 5-[[2-[(4-fluoro-3-methoxy-5-methylphenyl)amino]-5-methyl-4-pyrimidinyl]amino]-3-[(phosphonooxy)methyl]- 基本信息
MSDS 用途与合成方法 2(3H)-Benzoxazolone, 5-[[2-[(4-fluoro-3-methoxy-5-methylphenyl)amino]-5-methyl-4-pyrimidinyl]amino]-3-[(phosphonooxy)methyl]-价格(试剂级) 上下游产品信息
| 中文名称 | 2(3H)-Benzoxazolone, 5-[[2-[(4-fluoro-3-methoxy-5-methylphenyl)amino]-5-methyl-4-pyrimidinyl]amino]-3-[(phosphonooxy)methyl]- |
|---|---|
| 中文同义词 | 福西非丹西替尼;化合物FOSIFIDANCITINIB;(5-((2-((4-氟-3-甲氧基-5-甲基苯基)氨基)-5-甲基嘧啶-4-基)氨基)-2-氧代苯并[D]恶唑-3(2H)-基)甲基磷酸酯 |
| 英文名称 | 2(3H)-Benzoxazolone, 5-[[2-[(4-fluoro-3-methoxy-5-methylphenyl)amino]-5-methyl-4-pyrimidinyl]amino]-3-[(phosphonooxy)methyl]- |
| 英文同义词 | 2(3H)-Benzoxazolone, 5-[[2-[(4-fluoro-3-methoxy-5-methylphenyl)amino]-5-methyl-4-pyrimidinyl]amino]-3-[(phosphonooxy)methyl]-;Fosifidancitinib;Janus kinase,JAK,Inhibitor,Fosifidancitinib,inhibit;5-[[2-(4-fluoro-3-methoxy-5-methylanilino)-5-methylpyrimidin-4-yl]amino]-2-oxo-1,3-benzoxazol-3-yl]methyl dihydrogen phosphate;(5-((2-((4-Fluoro-3-methoxy-5-methylphenyl)amino)-5-methylpyrimidin-4-yl)amino)-2-oxobenzo[d]oxazol-3(2H)-yl)methyl dihydrogen phosphate;{[5-({2-[(4-fluoro-3-methoxy-5-methylphenyl)amino]-5-methylpyrimidin-4-yl}amino)-2-oxo-2,3-dihydro-1,3-benzoxazol-3-yl]methoxy}phosphonic acid |
| CAS号 | 1237168-58-9 |
| 分子式 | C21H21FN5O7P |
| 分子量 | 505.39 |
| EINECS号 | |
| 相关类别 | |
| Mol文件 | 1237168-58-9.mol |
| 结构式 | ![2(3H)-Benzoxazolone, 5-[[2-[(4-fluoro-3-methoxy-5-methylphenyl)amino]-5-methyl-4-pyrimidinyl]amino]-3-[(phosphonooxy)methyl]- 结构式](CAS/20210305/GIF/1237168-58-9.gif) |
2(3H)-Benzoxazolone, 5-[[2-[(4-fluoro-3-methoxy-5-methylphenyl)amino]-5-methyl-4-pyrimidinyl]amino]-3-[(phosphonooxy)methyl]- 性质
| 沸点 | 761.3±70.0 °C(Predicted) |
|---|---|
| 密度 | 1.564±0.06 g/cm3(Predicted) |
| 酸度系数(pKa) | 1.75±0.10(Predicted) |